Carmot Therapeutics

Carmot Therapeutics, based in San Francisco, is a biotechnology company dedicated to discovering and developing medicines for inflammatory, metabolic, and neurodegenerative diseases. Their core mission is to improve clinical outcomes for people living with obesity and diabetes through innovative therapies. Utilizing their proprietary Chemotype Evolution technology, Carmot aims to expand the therapeutic potential and address unmet medical needs in these areas.

Carmot Therapeutics has made significant strides in the biotechnology sector by focusing on groundbreaking scientific research and development. Their commitment to improving the lives of individuals with metabolic diseases has positioned them as a key player in the industry. The company's innovative approach and dedication to science have garnered attention and support from various stakeholders, contributing to their growing impact in the field of medicine.